Tolerability and Safety of Eflornithine (DFMO) in High-Risk Neuroblastoma (HRNB) Patients Treated with DFMO Maintenance Therapy

Tolerability and Safety of Eflornithine (DFMO) in High-Risk Neuroblastoma (HRNB) Patients Treated with DFMO Maintenance Therapy Jaqueline Kraveka, William Ferguson, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Donald A. Berry, Javier Oesterheld, Valerie I. Brown, Don E. Eslin, Derek Hanson, Virginia L. Harrod, Michael S. Isakoff, Deanna S Mitchell, William Roberts, Randal K. Wada, Peter Zage, Giselle Saulner Sholler  2023 ANR Annual Meeting, Amsterdam, Netherlands